Please join us for the oral presentation and moderated discussion of the top 36 abstracts submitted to the 2021 Virtual Diabetes Technology Meeting. This session is free for all to attend.
Moderators
Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, Maryland, USA
Jessica Castle, MD
Oregon Health & Science University, Portland, Oregon, USA
8:30 Outpatient Full Closed-Loop Trial Using An Open-Source Remote Monitoring and Artificial Pancreas Platform
Fabricio Garelli, PhD et al.
Presented by Emilia Fushimi, Eng.
8:34 Significant Reductions in Adverse Events and Hospitalizations with Control-IQ Technology in Adults with Type 1 Diabetes: Data from the CLIO Study
Jordan E. Pinsker, MD et al.
8:38 Impact of Real-World MiniMed™ 670G System Use on Glycemic Outcomes in the United States
Siddharth Arunachalam, MSc et al.
8:42 Real-World Outcomes of the MiniMedTM 780G System when Used with Optimal Settings
Arcelia Arrieta, MS et al.
Presented by Ohad Cohen, MD
8:46 Current Technology Use in Pediatric Patients with Type 1 Diabetes: An Equity-Focused Analysis
Katie Fogle, BS
8:50 Higher Dose of Inhaled Technosphere Insulin Provides Significant Reduction in Post Prandial Glucose Excursions, Without Hypoglycemia
Kevin Kaiserman, MD et al.
8:54 Q&A / Panel Discussion
Moderators
Julia Mader, MD, PhD
Medical University of Graz, Graz, Austria
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
9:15 Hyperoptimized DeepLearning Model For Glucose Prediction On DBLG1
Hector Romero-Ugalde, PhD et al.
9:19 Predicting Postprandial Glucose Excursions with Macronutrient Content using an Interpretable Random Forest Augmented by a Digital Twin ODE Model
Rahul Narayan, MS et al.
9:23 In Silico Trial to Quantitatively Measure How Much Different Behavioural Factors Influence Time in Hypoglycemia in Type 1 Diabetes Management
Chiara Roversi, MS et al.
9:27 Importance of Accounting for Correlation Among Noise Samples when Filtering CGM Data: A Simulation Study
Ilaria Siviero, MS et al.
Presented by Nunzio Camerlingo, MSc
9:31 Evaluation of the Safety and Efficacy of the Lalani Insulin Infusion Protocol
Benjamin Lalani et al.
9:35 Generation of Realistic Virtual Diabetes Patients Using a Pix2Pix GAN: In Pursuit of AI-based Diabetes Simulator
Omer Mujahid, MSc et al.
9:39 Q&A / Panel Discussion
Moderators
Boris Mankovksy, MD, PhD
Institute of Endocrinology, Kiev, Ukraine
Mike McShane, PhD
Texas A&M University, College Station, Texas, USA
10:00 Post-Market Clinical Surveillance of OneTouch Ultra® Plus Blood Glucose Test Strips
Steven Setford, PhD et al.
10:04 Clinical Evaluation of the Lumee™ Glucose System - A Fluorescence-Based long-term continuous glucose sensor
Ulrike Kamecke, Dipl-Ing (FH) et al.
10:08 Wearable Electrochemical Platform for Glucose Monitoring and Diabetes Management
Russell Potts, PhD et al.
10:12 Point-of-Care Insulin Monitoring Using Electrochemical Sensing
Clara Stroh et al.
10:16 1,5-Anhydroglucitol is an Independent Predictor of Mortality in Patients with COVID-19
Eric Button, MS, MBA et al.
10:20 Unsupervised Anomaly Detection Algorithms to Identify Compression Artifacts in Continuous Glucose Monitoring
Elena Idi, MS et al.
10:24 Q&A / Panel Discussion
Moderators
Hubert Vesper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Lori Laffel, MD, MPH
Joslin Diabetes Center Harvard Medical School, Boston, Massachusetts, USA
10:45 Improvements in Hypoglycemia and HbA1c with RT-CGM Adoption: Results from the COACH Study
Stayce Beck, PhD et al.
10:49 Long-Term (7-Year) Glycemic Outcomes with Continuous Glucose Monitoring (CGM) Initiation within First Year of Type 1 Diabetes (T1D) Diagnosis
Anagha Champakanath, MBBS et al.
10:53 Relationship between Time in Range, Glycemic Variability Metrics and Daily Scan Rate in Children with Type 1 Diabetes
Pietro Bosoni, MSc et al.
10:57 A Data-Driven Approach to Predict Carbohydrate Counting Errors in Diabetes Management
Sahaj Shah, BA et al.
11:01 Identifying Patients at High Risk for Cystic Fibrosis Related Diabetes through the use of the Freestyle LibrePro CGM
Jeniece Ilkowitz, RN, MA, CDE et al.
11:05 Upcycling of Used CGM to a Cool Chain Monitor for Insulin
Thomas Wuttke, Dipl.-Ing. et al.
11:09 Q&A / Panel Discussion
Moderators
Francisco Pasquel, MD, MPH
Emory University, Atlanta, Georgia, USA
Sultan Meo, MD, PhD, FRCP
King Saud University, Riyadh, Saudi Arabia
11:30 Phenolic Preservatives, Present in Commercial Insulins, Trigger Inflammation at Infusion Sites via Mast Cell Activation
Shereen Kesserwan, MS et al.
11:34 Rate of Unexplained Hyperglycemia and Infusion Set Occlusion: Medtronic Extended Infusion Set (EIS) Pivotal Trial and 3-day Infusion Set Study Comparison
Sarnath Chattaraj, PhD et al.
11:38 Potential Cost Savings from a Reduction in Sensor-detected Severe Hypoglycemia Among Users of the InPen Smart Insulin Pen System
Albert Chien, MA, MPH et al.
11:42 User Experiences with an Insulin Pen Platform
April Taylor, MSN, CNS et al.
11:46 Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Type 1 and Type 2 Diabetes Patients
Rachel S. Newson, PhD et al.
11:50 Determining losses in Jet-Injection Subcutaneous Insulin delivery
Alex McHugh, BE (Hons) et al.
11:54 Q&A / Panel Discussion
Moderators
Wei-An (Andy) Lee, DO
LAC+USC Medical Center, Los Angeles, California, USA
Jing Wang, PhD, MPH, RN, FAAN
Florida State University, Tallahassee, Florida, USA
12:15 Increased Time-in-Range after Meals When Using the SNAQ App
David Haldimann, MSc et al.
Presented by Aurelian Briner, MA
12:19 Representing Type 1 Diabetes Device Data Using CDISC Standards
John Owen, BSc et al.
Presented by Rebecca Baker, MS, MHA, BSN
12:23 Development of Self-Management Behavior Scores and Profiles with Digital Health Data
Michelle Dugas, PhD et al.
12:27 “Pre-Ramadan” Telemedicine: Effect on Fasting Experience & Glycemic Control during Ramadan in People with Type 1 Diabetes
Sahar Alharthi, MBBS et al.
12:31 The Effects of One Drop Digital Program on Glucose Control in Employees with Type 1 and 2 Diabetes
Lindsay Sears, PhD et al.
12:35 Virtual Care in the COVID-19 Era: Assessing Telemedicine Experiences among Diabetes Care and Education Specialists
Evelyn Cox, BA et al.
12:39 Q&A / Panel Discussion